Clinical Trial Results: What the Research Shows
These are from well‑controlled studies, where doses, follow‑ups, and support are more consistent than in everyday use:
| Study | Population | Dose(s) Used | Duration | Average Weight Loss | % of Participants Hitting Key Losses* |
|---|---|---|---|---|---|
| SURMOUNT‑1 (people without type 2 diabetes, overweight or obese) | BMI ≥30 or ≥27 + comorbidity | 5 mg / 10 mg / 15 mg weekly | 72 weeks (~1.4 years) |
16.0% (5 mg), 21.4% (10 mg), 22.5% (15 mg) compared to ~2.4% placebo. |
~89%‑96% lost ≥5% body weight; many got ≥10%, ≥15%, and ≥20%. |
| SURMOUNT‑2 (people with type 2 diabetes, obesity/overweight) | Obese or overweight + T2D | 10 mg / 15 mg weekly | 72 weeks | ~13.4% (10 mg) and ~15.7% (15 mg) average weight loss. | ≈81.6% (10 mg), ≈86.4% (15 mg) achieved ≥5% loss. |
| Other data (SURMOUNT‑4, etc.) | Overweight/obese adults | tirzepatide + lifestyle support | ~72‑84 weeks | Up to ~21% average body weight loss in initial phase; those who stopped treatment regained some weight; those who stayed on lost more. |
* “Key Losses” means achieving certain thresholds (5%, 10%, 15%, 20%) of weight loss relative to where someone started. Visit our site to know the cost of Mounjaro inections in Riyadh (سعر ابر مونجارو).
💬 What “Before & After” Stories Tend to Show (Anecdotal / Real‑World)
People’s real‑life experiences often echo the clinical findings, though with more variation. Here are some common patterns:
-
Many report noticeable weight loss in the first couple of months (often due to appetite reduction, water loss, initial side effects) but not everything is fat loss.
-
As weeks and months go by, more consistent losses — sometimes in the 10‑15% range after ~6‑9 months, especially when the dose is increased and adaptations (diet, exercise, sleep) are made.
-
Some report larger losses (~20‑30% of starting weight) over longer periods (12‑18 months), often with high doses (15 mg) plus good lifestyle support.
-
Maintenance or plateau phases also occur: once big losses happen, progress tends to slow, and some weight may creep back if the medication is reduced or lifestyle changes are not sustained.
⚠️ What to Keep in Mind
-
Dosage matters: Higher doses (10‑15 mg) tend to produce more dramatic weight loss in trials. Lower doses produce more modest results, especially early on.
-
Duration matters: The longer the treatment (up to certain safe limits), the more weight loss and often better maintenance.
-
Lifestyle & support (diet, exercise, medical monitoring) boost results. Medication alone tends to produce less.
-
Real‑world outcomes are often less aggressive than trial outcomes because trials have stricter controls, adherence, and participant selection.
-
Side effects are common, especially early (nausea, reduced appetite, gastrointestinal symptoms) and can affect how much and how fast someone can progress.
